Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics provides initial data on combination therapy with Reolysin in multiple myeloma patients

Dec 6 (Reuters) - Oncolytics Biotech Inc: 
    * Oncolytics Biotech Inc collaborators present initial 
results from REO 019 study in multiple myeloma combining 
Reolysin, bortezomib and dexamethasone at the ash annual 
meeting 
    * Oncolytics Biotech Inc - preliminary data suggest evidence 
of activity and that treatment combination was well tolerated 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nPn73fYh1a 
Further company coverage:  ONC.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Oncolytics Biotech

See all news